Hakutulokset - Ale Algra

Tarkenna hakua
  1. 1
    Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia.

    Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia. Tekijä Ale Algra, J. van Gijn

    Julkaistu 1996
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

    Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke Tekijä Frits R. Rosendaal, Ale Algra

    Julkaistu 1997
    Hae kokoteksti
    Carta
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial origin

    Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial origin Tekijä Ale Algra, J. van Gijn

    Julkaistu 1999
    Hae kokoteksti
    Carta
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Genetic variation in fibrinogen; its relationship to fibrinogen levels and the risk of myocardial infarction and ischemic stroke

    Genetic variation in fibrinogen; its relationship to fibrinogen levels and the risk of myocardial infarction and ischemic stroke Tekijä Bob Siegerink, F.R. Rosendaal, Ale Algra

    Julkaistu 2008
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Cost-Effectiveness of Aspirin Treatment in the Primary Prevention of Cardiovascular Disease Events in Subgroups Based on Age, Gender, and Varying Cardiovascular Risk

    Cost-Effectiveness of Aspirin Treatment in the Primary Prevention of Cardiovascular Disease Events in Subgroups Based on Age, Gender, and Varying Cardiovascular Risk Tekijä Jacoba P. Greving, Erik Buskens, Hendrik Koffijberg, Ale Algra

    Julkaistu 2008
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Endothelin Receptor Antagonists for Aneurysmal Subarachnoid Hemorrhage

    Endothelin Receptor Antagonists for Aneurysmal Subarachnoid Hemorrhage Tekijä Mervyn D.I. Vergouwen, Ale Algra, Gabriël J.E. Rinkel

    Julkaistu 2012
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Hypercoagulability Is a Stronger Risk Factor for Ischaemic Stroke than for Myocardial Infarction: A Systematic Review

    Hypercoagulability Is a Stronger Risk Factor for Ischaemic Stroke than for Myocardial Infarction: A Systematic Review Tekijä Alberto Maino, Frits R. Rosendaal, Ale Algra, Flora Peyvandi, Bob Siegerink

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Risk Factors for Intracerebral Hemorrhage in the General Population

    Risk Factors for Intracerebral Hemorrhage in the General Population Tekijä M.J. Ariesen, Steven Claus, Gabriël J.E. Rinkel, Ale Algra

    Julkaistu 2003
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Headache characteristics in subarachnoid haemorrhage and benign thunderclap headache

    Headache characteristics in subarachnoid haemorrhage and benign thunderclap headache Tekijä F. Linn, Gabriël J.E. Rinkel, Ale Algra, J. van Gijn

    Julkaistu 1998
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Cost-effectiveness of preventive treatment of intracranial aneurysms

    Cost-effectiveness of preventive treatment of intracranial aneurysms Tekijä Jacoba P. Greving, Gabriël J.E. Rinkel, Erik Buskens, Ale Algra

    Julkaistu 2009
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Prevalence and Risk of Rupture of Intracranial Aneurysms

    Prevalence and Risk of Rupture of Intracranial Aneurysms Tekijä Gabriël J.E. Rinkel, Mamuka Djibuti, Ale Algra, J. van Gijn

    Julkaistu 1998
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Cochrane Review: Dipyridamole for Preventing Major Vascular Events in Patients With Vascular Disease

    Cochrane Review: Dipyridamole for Preventing Major Vascular Events in Patients With Vascular Disease Tekijä E.L.L.M. De Schryver, Ale Algra, J. van Gijn

    Julkaistu 2003
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    Trial of secondary prevention with atenolol after transient ischemic attack or nondisabling ischemic stroke. The Dutch TIA Trial Study Group.

    Trial of secondary prevention with atenolol after transient ischemic attack or nondisabling ischemic stroke. The Dutch TIA Trial Study Group. Tekijä Ale Algra, L. Jaap Kappelle, Jeanette Van Latum, Peter J. Koudstaal

    Julkaistu 1993
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    Epilepsy Surgery in Tuberous Sclerosis: A Systematic Review

    Epilepsy Surgery in Tuberous Sclerosis: A Systematic Review Tekijä Floor E. Jansen, Alexander C. van Huffelen, Ale Algra, Onno van Nieuwenhuizen

    Julkaistu 2007
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    D-dimer for the exclusion of cerebral venous thrombosis: a meta-analysis of low risk patients with isolated headache

    D-dimer for the exclusion of cerebral venous thrombosis: a meta-analysis of low risk patients with isolated headache Tekijä Imanda M.E. Alons, Korné Jellema, Marieke J.H. Wermer, Ale Algra

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    Systematic review of randomized controlled trials of aspirin and oral anticoagulants in the prevention of graft occlusion and ischemic events after infrainguinal bypass surgery

    Systematic review of randomized controlled trials of aspirin and oral anticoagulants in the prevention of graft occlusion and ischemic events after infrainguinal bypass surgery Tekijä Marco J.D. Tangelder, James A. Lawson, Ale Algra, B.C. Eikelboom

    Julkaistu 1999
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Prevalence and Prognosis of Asymptomatic Vertebral Artery Origin Stenosis in Patients With Clinically Manifest Arterial Disease

    Prevalence and Prognosis of Asymptomatic Vertebral Artery Origin Stenosis in Patients With Clinically Manifest Arterial Disease Tekijä Annette Compter, H. Bart van der Worp, Ale Algra, L. Jaap Kappelle

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    Independent Risk Factors for Intracranial Aneurysms and Their Joint Effect

    Independent Risk Factors for Intracranial Aneurysms and Their Joint Effect Tekijä Monique H.M. Vlak, Gabriël J.E. Rinkel, Paut Greebe, Ale Algra

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Quality of Life in Patients and Partners After Aneurysmal Subarachnoid Hemorrhage

    Quality of Life in Patients and Partners After Aneurysmal Subarachnoid Hemorrhage Tekijä Jeannette W. Hop, Gabriël J.E. Rinkel, Ale Algra, J. van Gijn

    Julkaistu 1998
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Risk of Rupture of an Intracranial Aneurysm Based on Patient Characteristics

    Risk of Rupture of an Intracranial Aneurysm Based on Patient Characteristics Tekijä Monique H.M. Vlak, Gabriël J.E. Rinkel, Paut Greebe, Ale Algra

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: